(Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive review of the ...

The 2-year local recurrence-free survival (LRFS) improved from 76.0% without adjuvant RT to 87.1% with it. Disease-free (DFS) ...

Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...

In a recent conversation with CURE, Hensley discussed the current treatment landscape of non-muscle-invasive bladder cancer, ...

Adjuvant radiotherapy could substantially reduce risk for locoregional recurrence for patients with advanced muscle-invasive ...

The Urology Care Foundation has created new resources to provide support, hope and guidance to bladder cancer patients and ...

Immunocompromised patients with bladder cancer who undergo TURBT followed by BCG immunotherapy have worse survival outcomes compared to non-immunocompromised patients, a study suggests.

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Former NFL superstar Deion Sanders knows about bringing his top game, but he had to take that mindset to a new level after he ...